Clinical trials
Gallstones trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 3 |
| Beijing Friendship Hospital | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Air Force Military Medical University, China | 1 |
| American University of Beirut Medical Center | 1 |
| Asian Institute of Gastroenterology, India | 1 |
| Azienda Ospedaliero, Universitaria Pisana | 1 |
| Azienda Usl di Bologna | 1 |
| Chengyi Sun | 1 |
| China-Japan Friendship Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gallstones | 52 |
| Cholecystitis | 12 |
| Cholelithiasis | 12 |
| Choledocholithiasis | 5 |
| Cholecystolithiasis | 4 |
| Gallbladder Diseases | 4 |
| Bile Duct Diseases | 2 |
| Biliary Dyskinesia | 2 |
| Cholangiocarcinoma | 2 |
| Cholangitis | 2 |
Trials
Showing 76 to 52 of 52. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.